ArticlePloS one2022

Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.

Shunsuke Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.